文献库搜索 | GeneLibs

Watanabe(Y),Takigami(A),Hisata(S),Nakayama... Transl Lung Cancer Res 2026-03-23

...ALK (EML4-ALK) fusion variants have been identified, with variants 1-3 (V1-3) accounting for approximately 90% of cases....

Yoshimura(R),Yanagawa(N),Yamada(N),Tomoyas... Transl Lung Cancer Res 2026-03-23

...ALK) expression in non-small cell lung cancer (NSCLC) specimens. ALK-positive lung cancers resected from a 47-year-old w...

Yoon(D),Lee(JW),Cho(BC),Kang(EJ),Kim(JS),L... Transl Lung Cancer Res 2026-03-23

...ALK, and these were associated with worse clinical outcomes. Conversely, favorable responders showed enrichment of MTOR,...

Zhao(Y),Zhou(Y),Pan(L),Tian(GG),Huang(HY),... J Clin Invest 2026-04-15

...ALK fusion lung cancer induced cholesterol biosynthesis, which promoted cancer cells to enter dormancy and thus escape d...

Sakakida(T),Masuishi(T),Onoe(T),Komine(K),... Future Oncol 2026-05-00

...ALK-tyrosine kinase inhibitor (ALK-TKI), has shown potential efficacy in ALK fusion-positive tumors besides NSCLC, suppo...

Abad(MS),Abad-Casintahan(F),Casintahan(MEA... Am J Dermatopathol 2026-08-01

...ALK/EMA negative, consistent with ALK-negative systemic ALCL with cutaneous involvement. Staging revealed stage IV disea...

Hu(T),Zhang(Y),Mao(Y),Li(X),Liu(Y),Shi(M),... Environ Res 2026-06-15

...alkylated PAHs (Alk-PAHs), which may be more stable and toxic, potentially leading to a substantial underestimation of e...

Liu(J),Qian(F) Ann Med 2026-12-00

...alk between cancer cells and stromal components. This review systematically synthesizes the latest insights into the reg...

Jia(H),Zhong(Y),Lin(CLS),Mandrinos(S),Woon... J Thorac Dis 2026-03-31

...ALK toward emerging targets including HER2, KRAS, and TROP2, as well as resistance mechanisms, immunotherapy combination...

Chen(KY),Chan(HC),Chan(CM) Infection 2026-08-00

...ALK), contemporary pooled incidence estimates stratified by surgical technique and geographic region are required to inf...